Navigation Links
The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
Date:10/31/2008

f employers remember that -- just like job searching -- fulfillment is an ongoing process. "It requires continuous assessing, planning, guiding, and nurturing," said Michele Hopps, director of marketing for MedZilla.com. "Recruiters can help, but if companies haven't made provisions for filling their new jobs, they will stand open until someone happens upon them on a job search site."

About MedZilla.com:
Established in mid-1994, MedZilla is the original web site to serve career and hiring needs for professionals and employers in biotechnology, pharmaceuticals, medicine, science and healthcare. The MedZilla jobs database contains about 7,500 open positions. The resume database currently contains over 285,000 resumes with 16,800 less than three months old. These resources have been characterized as the largest, most comprehensive databases of their kind on the web in the industries served.

Medzilla® is a Registered Trademark owned by Medzilla Inc. Copyright ©2008, MedZilla, Inc. Permission is granted to reproduce and distribute this text in its entirety, and if electronically, with a link to the URL www.medzilla.com. For permission to quote from or reproduce any portion of this message, please contact Michele Hopps, Director of Marketing and Development, MedZilla, Inc. Email: mgroutage(at)medzilla.com.

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1551984.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
4. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
5. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
6. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
7. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
8. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
9. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
10. American Oriental Bioengineering Announces Participation in September Investor Conferences
11. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Care at Hahnemann among the Best in the ... Hahnemann University Hospital proudly announces it has been ... Center,s (ANCC) Magnet Recognition Program(R). Magnet(R) is one ... or medical center can achieve, and places Hahnemann ... country that have achieved this prestigious distinction. ,, ...
(Date:12/16/2009)... Mass., Dec. 16 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, according ... Stelara and Abbott,s briakinumab (both interleukin inhibitors) will ... 2012 in the drug market for moderate to ... experience greater uptake, capturing nearly three times as ...
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/15/2009)... Dec. 15 Epeius Biotechnologies Corporation, an ... medicine, gained international validation of the cutting-edge science ... when scientists around the world rediscovered the ... locus of cancer pathogenesis and disease progression, and ... scientists at the NIH National Cancer Institute investigating ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... Ill., Oct. 23 Opponents of Michigan,s stem,cell ... ad yesterday using,the tragic and universally reprehensible Tuskegee ... research. This ad is replete with myths and,misinformation. ... cell research are many, and it is important ...
... Ltd (BioWisdom),the market leader in delivering healthcare ... release of OmniViz,Visualization Software for Patent Specialists., ... in competitive business and,technical intelligence analyses to ... can turn the analysis of thousands of,patents ...
... Brings Hope and Awareness to Millions of Couples ... Ferring Pharmaceuticals is,honoring 12 lucky families who won ... their heart-warming and inspirational stories of their,journey to ... the,help of Ferring,s family of fertility products. The ...
Other Biology Technology:Anti-Stem-Cell-Research Ad Ignores Facts 2Anti-Stem-Cell-Research Ad Ignores Facts 3Ferring Celebrates Winner of 2008 My Little Miracle Essay Contest During National Infertility Awareness Week 2Ferring Celebrates Winner of 2008 My Little Miracle Essay Contest During National Infertility Awareness Week 3Ferring Celebrates Winner of 2008 My Little Miracle Essay Contest During National Infertility Awareness Week 4
(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... solutions, today announced that SC Magazine, one ... named BIO-key International the 2009 Innovator of ... Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ... SC Magazine, "Biometric providers have been trying ...
(Date:12/16/2009)... Dec. 16 European Union (EU) ... their borders, which are increasingly subjected to ... investment in advanced technology security and IT-based ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, New ... ), Border Security Market Assessment - ...
(Date:12/15/2009)... COLUMBIA, Mo. As soon as babies are ... as jaundice and e-coli. For up to a month, ... Although these infections are often minor, they can lead ... newborns, immune systems, University of Missouri researchers have pinpointed ... lead to an immune-strengthening vaccine. , "We,re trying to ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3Researchers work on vaccine to improve immune system in newborns 2Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 1Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 2Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 3Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 47500 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 1Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 5Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 1Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 2Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 3
... Parkinson,s Research today announced approximately $2.4 million in ... Target Validation initiative. This annual MJFF program provides ... PD drug targets forward toward clinical trials and ... , "The discovery of a new potential therapeutic ...
... for almost 50% of crop sales in the United ... good quality. But more information is needed about the ... so that management practices such as irrigation can be ... because of variations in crops, planting densities, and cultural ...
... AIDS Vaccine Advocacy Coalition (AVAC) today urged Dr. Anthony Fauci ... (NIAID) to act swiftly to clarify the path ahead suggested ... the proposed PAVE 100 AIDS vaccine trial but would, instead, ... calls on leaders in the field to make clear commitments ...
Other Biology News:Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's 2Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's 3Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's 4Digital cameras, remote satellites measure crop water demand 2AVAC comments on NIAID decision not to move forward with PAVE 100 Trial 2AVAC comments on NIAID decision not to move forward with PAVE 100 Trial 3
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
Anti-TNKS2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
... is involved in translation initiation. PHAS-II is ... bind to eIF-4E, the mRNA cap-binding protein, ... vitro and in cells. Phosphorylation in the ... This allows eIF-4E to bind to eIF-4G ...
... Monoamine Transporter 2 (VMAT2). An antibody made ... major band at ~55 kDa in postnuclear ... not in wild type cells (2). Some ... weight, were also detected and remain unaffected ...
Biology Products: